Last updated: July 09, 2026

Application No. 19/353,469

Untitled Application

Unknown

Filed

1600

Priority

Jun 03, 2024 — provisional 63/655,526 +1 more

Examiner

WESTON, ALYSSA G

Art Unit

1633

Tech Center

BioTissue Holdings Inc.

Assignee

BIOTISSUE HOLDINGS INC.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +48.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 105 resolved cases, 2023–2026

Examiner Intelligence

WESTON, ALYSSA G View full profile →

Grants 62% of resolved cases

Career Allowance Rate

65 granted / 105 resolved

+1.9% vs TC avg

Strong +48% interview lift

Without

With

+48.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

48 currently pending

Career history

170

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

31.3%

-8.7% vs TC avg

§102

47.5%

+7.5% vs TC avg

§112

2.7%

-37.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 105 resolved cases

Prosecution Timeline

1600

Application Filed

Apr 02, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/630,620

Patent 12668781

MATERIALS AND METHODS FOR THE MANUFACTURE OF PLURIPOTENT STEM CELLS

2y 2m to grant Granted Jun 30, 2026

18/218,896

Patent 12624338

METHOD AND DEVICE FOR TARGET CELL SEPARATION

2y 10m to grant Granted May 12, 2026

18/313,126

Patent 12599678

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

2y 11m to grant Granted Apr 14, 2026

17/928,092

Patent 12569539

Adipocytes Over-Expressing FFAR4 and Use Thereof

3y 3m to grant Granted Mar 10, 2026

17/050,527

Patent 12473342

Chimeric Antigen Receptor T Regulatory Cells for the Treatment of Atherosclerosis

5y 0m to grant Granted Nov 18, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

99%

With Interview (+48.5%)

3y 5m

Median Time to Grant

Low

PTA Risk

Based on 105 resolved cases by this examiner. Grant probability derived from career allowance rate.